We've found
6,735
archived clinical trials in
Psoriasis
We've found
6,735
archived clinical trials in
Psoriasis
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Updated: 12/13/2017
A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis
Updated: 12/14/2017
A Study to Evaluate the Efficacy and Safety of HAT01H, a Novel Topical Therapeutic: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/14/2017
A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis
Updated: 12/14/2017
A Study to Evaluate the Efficacy and Safety of HAT01H, a Novel Topical Therapeutic: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
A Study of Golimumab in Participants With Active Psoriatic Arthritis
Updated: 12/20/2017
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
Enstilar in Combination With Biologic Agents
Updated: 12/29/2017
An Open-Label, Study Evaluating Enstilar® (Calcipotriene and Betamethasone Dipropionate) Foam, 0.005%/0.064% QD in Psoriasis Patients Being Treated With Biologic Agents
Status: Enrolling
Updated: 12/29/2017
Enstilar in Combination With Biologic Agents
Updated: 12/29/2017
An Open-Label, Study Evaluating Enstilar® (Calcipotriene and Betamethasone Dipropionate) Foam, 0.005%/0.064% QD in Psoriasis Patients Being Treated With Biologic Agents
Status: Enrolling
Updated: 12/29/2017
Click here to add this to my saved trials
Twice Daily Versus Twice Weekly Soak-and-Seal Baths in Pediatric Atopic Dermatitis
Updated: 1/5/2018
Twice Daily Versus Twice Weekly Soak-and-Seal Baths in Pediatric Atopic Dermatitis: A Randomized, Single-blinded, Prospective Crossover Controlled Trial
Status: Enrolling
Updated: 1/5/2018
Twice Daily Versus Twice Weekly Soak-and-Seal Baths in Pediatric Atopic Dermatitis
Updated: 1/5/2018
Twice Daily Versus Twice Weekly Soak-and-Seal Baths in Pediatric Atopic Dermatitis: A Randomized, Single-blinded, Prospective Crossover Controlled Trial
Status: Enrolling
Updated: 1/5/2018
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/s
Updated: 1/9/2018
A Randomized, Doubleblind, Vehicle-controlled, Parallel-group Trial to Assess the Efficacy, Safety and Tolerability of P-3073 for Topical Treatment of Nail Psoriasis
Status: Enrolling
Updated: 1/9/2018
Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/s
Updated: 1/9/2018
A Randomized, Doubleblind, Vehicle-controlled, Parallel-group Trial to Assess the Efficacy, Safety and Tolerability of P-3073 for Topical Treatment of Nail Psoriasis
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/s
Updated: 1/9/2018
A Randomized, Doubleblind, Vehicle-controlled, Parallel-group Trial to Assess the Efficacy, Safety and Tolerability of P-3073 for Topical Treatment of Nail Psoriasis
Status: Enrolling
Updated: 1/9/2018
Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/s
Updated: 1/9/2018
A Randomized, Doubleblind, Vehicle-controlled, Parallel-group Trial to Assess the Efficacy, Safety and Tolerability of P-3073 for Topical Treatment of Nail Psoriasis
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials